This reinforces the importance of appropriate use of smoking cessation aids and assistance from suitably trained health professionals at the time of initiating smoking cessation medications and in their ongoing monitoring.
At the six-month follow-up interview, the 30-day point prevalence smoking abstinence, use of the CD in the previous 30 days, use of other cessation aids, BAI, BDI-V, and adverse events were investigated.
Primary outcomes included (1) intervention reach, (2) self-reported 7-day point prevalence abstinence rates at 3 months and 12 months, and 3) relative cost-effectiveness.Reach of the Internet intervention and use of smoking cessation aids were significantly greater compared to the control.
Time-varying covariates were measured at the time 1 interview of each dyad, except for use of other cessation aids (prescription cessation medication and behavioral support) that were measured at the time 2 interview.
The success rate of smoking cessation was also very different between the groups, which may be explained by differences in smoking cessation programs, including clinical care setting, the use of smoking cessation aids e.g drugs and the intensity of counselling.
Thus, CAM practitioners potentially represent a large, untapped community resource for promoting tobacco cessation and use of effective cessation aids.
Previous research indicates that barriers to the use of these cessation aids include concerns with their addictiveness, cost and side effects, as well as the belief that no treatment of any kind is needed to quit smoking.
4 Despite the fact that smoking cessation treatments, including counselling, 5 nicotine replacement therapy (NRT) 6 and other pharmacotherapies 7 can significantly improve the odds of quitting, the use of such smoking cessation aids is modest.
The programme announced today is as follows: Smoking cessation: The Nice appraisal will provide GPs with cost and clinical effectiveness evidence for the use of the smoking cessation aids NRT and bupropion (Zyban) in primary care.
